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day of the adaptation phase and then 7, 14 and 21 th day of yoghurt consumption phase and fi nally 26 and 28 th day of wash out period. We registered diff erent eff ect of probiotics and synbiotics on Clostridium sp. and Escherichia coli (E. coli) counts in human digestive system. Consumption of probiotics decreased of E. coli count and consumption of synbiotics increased of both E. coli count and Clostridium sp. in human digestive system.
probiotics, synbiotics, intestinal microfl ora
Intestinal microfl ora plays a key role in function of human digestive system. Bacteria presented in gastrointestinal system have an important function in development human immunity and protection of human health in global. Intestinal microfl ora is very variable and complex. It consists of more than 400 diff erent bacteria species. Microbial colonisation of gastrointestinal system is very individual, it develops during human life and it is also aff ected by external conditions. Bacterial colonisation is not equal in the whole intestine. There are lactobacilli, coliform bacteria, streptococci, bifi dobacteria and fusobacteria in the small intestine, whereas bacteroides, bifi dobacteria, streptococci, eubacteria, fusobacteria, coliform bacteria, clostridia, lactobacilli, staphylococci, yeasts, pseudomonas and Proteus are present in the large intestine (Švestka, 2008) .
Not only presence but also balance in microbial species distribution at the fi rst place is crucial for normal digestive process. This balance can be easily corrupted by antibiotic treatment, infections, immunity disorders, diarrhoea or intestinal constipation. Therefore is an eff ort to re-establish the balance using living microorganisms of human origin called probiotics (Saulnier et al., 2009; Watson, Preedy, 2010; Koning et al., 2010) .
Probiotics have positive eff ect on human health and maintain the balance of intestinal microfl ora (Rayes et al., 2008) . However, not every specimen containing microorganisms can be called probiotic, because it must fulfi l fundamental conditions. It must be eff ective, safe, using living bacteria and it must not be pathogenic. Probiotics must be made from bacteria of human provenance, they have to be resistant against digestive fl uids and bile and they also have to be adhesive to intestinal epithelium (Santos et al., 2010) .
Principle of probiotics is known nearly 100 years and their importance in medicine is growing lately. Positive eff ect of probiotics was proven in curing many diseases such as diarrhoea, unspecifi c intestine infl ammation, allergies or cancer genesis (Vrese, Schrezenmeir, 2008) . Regular consumption of probiotics in effi cient amount is crucial for reducing or neutralizing the symptoms (Uyeno et al., 2007) . 100 g of diary product containing at least 10 6 probiotic bacteria in 1g is considered to be therapeutic minimum (Granato et al., 2010) .
Positive health eff ect of probiotics consumption was observed during treatment of gastrointestinal system diseases including infection caused by viruses (Gill, 2003) . On the other hand, there are studies where positive eff ect of probiotics or synbiotics was not proven in patients suff ering from nosocominal infections (Vouloumanou et al., 2009) .
Consuming probiotics is not only one way how to re-establish balance of intestinal microfl ora. Another method is consuming indigestible parts of nutriment called prebiotics stimulating growth of one or more bacteria in the intestine (Krutmann, 2009) . Optimal is consuming probiotics and prebiotics that selectively support growth of a particular microorganism. The aim of these so called synbiotics is increasing survival of probiotic microorganisms (bifi dobacteria and lactobacilli) and maintaining their viability. Positive eff ect of synbiotics on growth intestinal microfl ora was proven using laboratory animals (Quigley, 2010; Quigley, 2011) . Yoghurt for human consumption is very suitable synbiotic containing probiotic bifi dobacteria and prebiotic oligofructose or inulin.
Consuming probiotics, prebiotics or synbiotics in order to improve condition of intestinal microfl ora is becoming very popular both in human and veterinary medicine in prevention or curing diseases. That is why probiotics are subject of important clinical research. Eff ective utilising of probiotics or synbiotics in treating human diseases is dependent on enough studies concerning with infl uence of particular probiotic microorganism on intestinal microfl ora. (Li et al., 2007; Ojetti et al., 2009; Maragkoudakis et al., 2010; Wallace et al., 2011) . Research should be especially focus on those bacteria, that can negatively aff ect homeostasis of gastrointestinal system.
Only o few combinations of pre/probiotics have been evaluated as synbiotics, with only a limited number determining eff ects on the human faecal microbiota using reliable molecular techniques (Saulnier et al., 2009) .
The aim of this study was to compare the eff ect of consumed probiotics and synbiotics on quantitative distribution of selected species of human intestinal microfl ora. We attempted to prove whether probiotics have greater eff ect on E. coli and Clostridium sp. counts in human intestine microfl ora than synbiotics.
MATERIALS AND METHODS
Three groups of subjects were determined in order to monitor eff ect of probiotics of synbiotics consumption. Group C (control) did not consume fermented dairy products during the study, group P (probiotic) consumed 200 g of white farm yoghurt containing probiotic BIFI culture and Lactobacillus acidophilus and group S (synbiotic) consumed 200 g of white farm yoghurt containing probiotic BIFI culture, Lactobacillus acidophilus and inulin.
Every group contained 22 persons at average age 22 ± 3 years. The experiment began with 10 day adaptation phase followed by 21 days of consuming yogurt (200 g per day) and fi nished by 7 days of fading phase without consuming fermented dairy products. Faecal samples were collected six times during the experiment: 0 (end of adaptation phase), 7, 14, 21 (eating yoghurt phase), 26 and 28 th day (fading phase) of the experiment.
Faecal samples were collected using sterile sampling swabs with activated charcoal (Vitrum, Czech Republic). Nutrient Broth Peptone medium (Himedia, Italy) was used for sample incubation. Cultivation was carried out on agar plates with diff erent nutrient medium in order to determine particular groups of microorganisms. ENDO agar (Biokar Diagnostics, France) was used for aerobic cultivation at 37 °C, 72 hours of E. coli. Anaerobic agar (Himedia, Italy) was used for anaerobic cultivation of Clostridium sp. Agar plates with Clostridium sp. were treated at 85 °C for 10 minutes before microbiological determination and CFU counting in order to inactivate the bacteria. Colonies arose a er cultivation was counted on every Petri dish and the amount of CFU in 1 g of the sample was calculated. Selected colonies were isolated and purifi ed on selective growth media.
Microbiological parameters were determined twice for every collected sample and average of these two measurements was used for statistical data evaluation. Program Statistica 8 (StatSo Inc., Tulsa, OK, USA) was used for determining basic statistical characteristics and regression curves (testing of quadratic function), diff erences between groups of samples in numbers of bacterial colonies (singleclassifi cation analysis of variance including post hoc Duncan test). Identifi cation of bacterial species was done using cooperation with the Czech Collection of Microorganisms in Brno.
RESULTS AND DISCUSSION
The aim of this study was comparing the eff ect of consuming probiotics and synbiotics on quantitative distribution of selected species of human intestinal microfl ora. The main purpose was to determine if probiotics have greater eff ect on E. coli and Clostridium sp. counts in human intestine than synbiotics.
We registered positive eff ect of both probiotic and synbiotic yoghurt on E. coli and Clostridium sp. counts during the experiment. Eff ect of synbiotics was detectable at the end of the adaptation phase when Clostridium sp. count was higher than in the group consuming probiotics (Fig. 1) . Clostridium sp. count decreased till 14 th day of synbiotics consumption and then it increased again. On the contrary, consuming probiotics did not signifi cantly aff ect numbers of observed bacteria. However, 7, 14 and 21 st day a er consuming probiotics the numbers of E. coli and Clostridium sp. were slightly lower.
The increase Clostridium sp. count can negatively aff ects numbers of other important bacteria participating in normal digestive functions of the gastrointestinal system. The increase of Clostridium sp. count can be connected with digestion disorders (diarrhoea) or nosocominal infections (Berild et al., 2003; Ben-Horin et al., 2009 ). Higher count of Clostridium sp. in intestine of healthy individuals did not negatively eff ects the health of the organism. On the other hand, higher count of this bacteria can negatively aff ect the health in immunodefi cient individuals.
We have detected decrease of E. coli counts a er consuming synbiotics during the whole experiment (Fig. 2) . The decrease was statistically signifi cant 7, 14, 21 and 28 th day a er consuming synbiotics. Eff ect of synbiotics on of E. coli counts was already registered in older studies (Huang et al., 2004; Ferreira et al., 2008; Lee et al., 2009) . However, this eff ect was not studied directly in human digestive system but on biofi lm in the in vitro culture (Smith et al., 2011) . It is obvious that synbiotics used in our study had double eff ect. The fi rst, it has a negative eff ect on the intestinal microfl ora represented by increasing Clostridium sp. count in the intestine. The second, a positive eff ect demonstrated by decreasing E. coli count.
In contrast to synbiotics, probiotics have relatively lower eff ect on both E. coli and Clostridium sp. counts ( Fig. 1 and 2 ). Fig. 1 shows that consuming probiodics did not signifi cantly aff ect Clostridium sp. counts in intestine. We can therefore assume that consuming probiotics does not limit both healthy and immunodefi cient individuals, which was already described by Palaria et al. (2011) and Shieh et al. (2011) . It is clear that probiotics signifi cantly decrease E. coli counts 14 days a er yoghurt consumption (p < 0.05). However, the eff ect of probiotics was lower than the eff ect of synbiotics from 14 th to 28 th day a er consuming yoghurt. Fig. 2 shows that the eff ect of probiotics on E. coli counts is higher from 14 th day and then the eff ect was lower than using synbiotics. This situation can be expected because the prebiotics represent the nutrient substrate, which prolongs viability of probiotic contained in synbiotic, and it leads to protracted eff ect (Collado et al., 2006) .
SUMMARY
This experiment showed, that there exist signifi cant diff erence between eff ect of probiotics and synbiotics on Clostridium sp. and E. coli counts in human intestine. Probiotic helps to decrease E. coli counts and synbiotic in addition has a positive eff ect on Clostridium sp. counts. We can therefore assume, that synbiotics consumption can be more positive than probiotics, especially for healthy people.
